Brown & Brown (BRO)
(Delayed Data from NYSE)
$112.43 USD
+2.08 (1.88%)
Updated Nov 8, 2024 04:00 PM ET
After-Market: $112.41 -0.02 (-0.02%) 7:58 PM ET
2-Buy of 5 2
F Value C Growth D Momentum F VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$112.43 USD
+2.08 (1.88%)
Updated Nov 8, 2024 04:00 PM ET
After-Market: $112.41 -0.02 (-0.02%) 7:58 PM ET
2-Buy of 5 2
F Value C Growth D Momentum F VGM
Zacks News
Arthur J. Gallagher (AJG) Announces Stellar Benefits Buyout
by Zacks Equity Research
Arthur J. Gallagher (AJG) acquires Stellar Benefits to boost its benefits capabilities throughout Northeastern Ohio.
MMC vs. BRO: Which Stock is Better Placed for Your Portfolio?
by Zacks Equity Research
Brown & Brown (BRO) and Marsh & McLennan (MMC) are poised to grow in the thriving insurance brokerage space. Based on certain parameters, we try to find out which stock is better than the other.
Arthur J. Gallagher (AJG) Announces Excess Underwriting Buyout
by Zacks Equity Research
Arthur J. Gallagher (AJG) acquires Excess Underwriting Company to unveil products in the Canadian marketplace.
Assurant (AIZ) Buys Remainder of Olivar, Boosts Mobile Solution
by Zacks Equity Research
Assurant (AIZ) buys remaining shares in Olivar to reinforce its footprint in the Asia Pacific region and strengthen its global asset disposition services.
Arthur J. Gallagher (AJG) Buys Remainder of Hesse & Partner
by Zacks Equity Research
Arthur J. Gallagher (AJG) acquires Hesse & Partner to strengthen its presence in Europe.
Arthur J. Gallagher (AJG) Up 52% in a Year: More Upside Left?
by Zacks Equity Research
Strong results at Brokerage and Risk Management segments and solid cash flows continue to aid Arthur J. Gallagher (AJG).
Reasons to Add Brown & Brown (BRO) Stock to Your Portfolio
by Zacks Equity Research
Brown & Brown's (BRO) impressive growth is driven by organic and inorganic means across all segments.
Aon (AON) Takes Initiatives for Pending Willis Towers Buyout
by Zacks Equity Research
Aon (AON) to divest its U.S. retirement business to accelerate the proposed Willis Towers-Aon merger.
Marsh & McLennan's (MMC) Unit Surpasses the $390 Billion Mark
by Zacks Equity Research
Marsh & McLennan's (MMC) subsidiary crosses the $390-billion mark in assets under management (AUM).
Stewart Information (STC) Consolidates Commercial Operations
by Zacks Equity Research
Stewart Information's (STC) buyout of Thomas Title & Escrow will help it expand presence in the commercial operations.
Why Should You Add Nasdaq (NDAQ) Stock to Your Portfolio?
by Zacks Equity Research
Nasdaq's (NDAQ) significant and leading positions in large, high growth markets like Index, Analytics, Market Technology, and IR & ESG Services bode well for growth.
Why Should You Add Marsh & McLennan (MMC) to Your Portfolio?
by Zacks Equity Research
Banking on revenue growth and judicious strategic actions, Marsh & McLennan (MMC) holds promises to be an attractive bet for yield-seeking investors.
Arthur J. Gallagher (AJG) Buys AOBG, Expands in Affinity Market
by Zacks Equity Research
Arthur J. Gallagher (AJG) acquires AOBG to enhance its capabilities in the Affinity market.
eHealth (EHTH) Grows on Segmental Strength, Cost Woes Stay
by Zacks Equity Research
eHealth (EHTH) is set to grow riding on gradual shift in telesales and substantial increase in estimated lifetime values of individual and family plan members.
Brown & Brown (BRO) Down 0.1% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Brown & Brown (BRO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Arthur J. Gallagher (AJG) Announces Garner & Glover Buyout
by Zacks Equity Research
Arthur J. Gallagher (AJG) enhances insurance services with Garner & Glover buyout.
Brown & Brown (BRO) Boosts Benefits Service With Piper Jordan
by Zacks Equity Research
Brown & Brown (BRO) completes the buyout of Piper Jordan to enhance its employee benefits services.
Alleghany (Y) Acquires Wilbert With Piedmont Manufacturing
by Zacks Equity Research
Alleghany (Y) acquires Wilbert to boost its non-insurance revenues and increase its geographical presence.
ProAssurance's (PRA) Q1 Earnings Beat Estimates, Surge Y/Y
by Zacks Equity Research
ProAssurance's (PRA) Q1 results reflect reduced expenses, partly offset by lower premiums.
Brown & Brown (BRO) Is Up 5.35% in One Week: What You Should Know
by Zacks Equity Research
Does Brown & Brown (BRO) have what it takes to be a top stock pick for momentum investors? Let's find out.
eHealth (EHTH) Shares Rise on Q1 Earnings Beat, Revenues Up Y/Y
by Zacks Equity Research
eHealth (EHTH) stock up on first-quarter earnings beat attributable to solid revenue growth, courtesy of well-performing Medicare, and Individual, Family and Small Business segments.
Aon's (AON) Q1 Earnings Surpass Estimates, Increase Y/Y
by Zacks Equity Research
Aon's (AON) Q1 results reflect higher revenues in its Reinsurance Solutions, Retirement Solutions Health Solutions and Commercial Risk Solutions segments.
CNO Financial's (CNO) Q1 Earnings Beat Estimates, Fall Y/Y
by Zacks Equity Research
CNO Financial's (CNO) first-quarter results reflect improved revenues, partly offset by steep expenses.
Willis Towers (WLTW) Q1 Earnings & Revenues Beat, Up Y/Y
by Zacks Equity Research
Willis Towers' (WLTW) first-quarter results highlight strong performances across the company's segments barring Investment, Risk & Reinsurance, partly offset by rise in costs.
Marsh & McLennan's (MMC) Q1 Earnings Surpass, Improve Y/Y
by Zacks Equity Research
Marsh & McLennan's (MMC) Q1 earnings reflect better revenues from both its reportable segments.